Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Evelina Blomberg"'
Autor:
Traimate Sangsuwan, Ali Pour Khavari, Evelina Blomberg, Tajanena Romell, Paulo Roberto D'auria Vieira De Godoy, Mats Harms-Ringdahl, Siamak Haghdoost
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 28, Iss 11, p 296 (2023)
Background: Exposure to low dose rate (LDR) radiation may accelerate aging processes. Previously, we identified numerous LDR-induced pathways involved in oxidative stress (OS) and antioxidant systems, suggesting that these pathways protect against pr
Externí odkaz:
https://doaj.org/article/a9b55fbed3164bf4b0beb1369eeeccfb
Publikováno v:
Translational Oncology, Vol 28, Iss , Pp 101607- (2023)
Despite multimodal treatment approaches including surgery, radiotherapy and chemotherapy, the median survival for patients with glioblastoma remains in the range of one year and thus poor. Type I interferons (IFN) are involved in immune responses to
Externí odkaz:
https://doaj.org/article/4b1e6e8cf4bb40aab218baf260eb1d70
Autor:
Isabell Hultman, Linnea Haeggblom, Ingvild Rognmo, Josefin Jansson Edqvist, Evelina Blomberg, Rouknuddin Ali, Lottie Phillips, Bengt Sandstedt, Per Kogner, Shahrzad Shirazi Fard, Lars Ährlund-Richter
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190970 (2018)
In this study chemotherapy response in neuroblastoma (NB) was assessed for the first time in a transplantation model comprising non-malignant human embryonic microenvironment of pluripotent stem cell teratoma (PSCT) derived from diploid bona fide hES
Externí odkaz:
https://doaj.org/article/7a4cd87ab1b54d3e938a8eda7b72035f
Background Glioblastoma is the most common brain tumor in adults and virtually incurable. Therefore, new therapeutic strategies are urgently needed. Immune checkpoint inhibition has not shown activity in various phase III trials and intra- as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818fd5a35f7f2723c9e310e572f2b7a6
Autor:
Linnea Haeggblom, Bengt Sandstedt, Lottie Phillips, Lars Ährlund-Richter, Isabell Hultman, Ingvild Rognmo, Per Kogner, Rouknuddin Ali, Josefin Jansson Edqvist, Evelina Blomberg, Shahrzad Shirazi Fard
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190970 (2018)
PLoS ONE
PLoS ONE
In this study chemotherapy response in neuroblastoma (NB) was assessed for the first time in a transplantation model comprising non-malignant human embryonic microenvironment of pluripotent stem cell teratoma (PSCT) derived from diploid bona fide hES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f56ae0aed0c7795e879798b5c390cf
http://europepmc.org/articles/PMC5771584?pdf=render
http://europepmc.org/articles/PMC5771584?pdf=render
Publikováno v:
American journal of stem cells. 5(1)
Hearing impairment most often involves loss of sensory hair cells and auditory neurons. As this loss is permanent in humans, a cell therapy approach has been suggested to replace damaged cells. It is thus of interest to generate lineage restricted pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::109fec165eb7238798f364e990d75ee4
https://pubmed.ncbi.nlm.nih.gov/27335699
https://pubmed.ncbi.nlm.nih.gov/27335699
Publikováno v:
Seminars in cancer biology. 29
Xenografting is the so far only available in vivo model for assessing pluripotency of human stem cells. This review describes known biological features of experimental teratoma from human pluripotent stem cells. We focus on the dual nature mimicking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c928634e401dbc02db92c249b7db89c
https://pubmed.ncbi.nlm.nih.gov/25153353
https://pubmed.ncbi.nlm.nih.gov/25153353